The Paradigm Evolves
November 13 – 14, 2019 • Harvard Medical School, Boston, MA
The 15th Annual Personalized Medicine Conference at Harvard Medical School will explore the science, business, and policy issues facing personalized medicine as scientists refine their understanding of how groundbreaking molecular diagnostics augmented by artificial intelligence, advanced data analytics, and digital health applications can empower both physicians and patients with information about how an expanded set of biological characteristics — including those found in the proteome and microbiome — may influence their health and their responses to increasingly impactful therapies.
Bonnie J. Addario
GO2 Foundation for Lung Cancer
Kris Joshi, Ph.D.
Executive Vice President; President, Network Solutions
Lincoln Nadauld, M.D., Ph.D.
Chief, Precision Health
Kenna R. Mills Shaw, Ph.D.
MD Anderson Institute for Personalized Cancer Therapy
Michael Sherman, M.D., M.B.A., M.S.
Chief Medical Officer, Senior Vice President
Harvard Pilgrim Health Care
Harpreet Singh, Ph.D.
Roy Smythe, M.D.
Paul Stoffels, M.D.
Vice Chairman, Executive Committee; Chief Scientific Officer
Johnson & Johnson
Meg Tirrell (invited)